The Procter & Gamble Company

The Procter & Gamble Company

PGNYSE / NASDAQConsumer DefensiveLarge cap

$169.37+$1.52 (+0.9%)

Last close · Data as of Nov 20, 2026

Market cap
$327.8B
P/E
20.9x
EV / EBITDA
14.8x
Revenue
$84.3B
Net margin
18.6%
ROCE
24.6%

+14.3% over the last year

The Procter & Gamble Company price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
+6.3%
3M
+18.5%
6M
+18.9%
1Y
+14.3%
5Y
+15.4%

52-week range

Day change +$1.52 (+0.9%) from $168 to $169 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in PG, bought on each weekday since 2021.

News & filings

What The Procter & Gamble Company filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

StrengthReturn on capital employed of 24.6%.

Concerns (1)

  • Current assets are 0.70 times current liabilities.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care segments.

Read moreShow less

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care segments. The company offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; antiperspirants, deodorants, and personal cleansing products under the Native, Old Spice, Safeguard, and Secret brands; and facial moisturizers, cleaners, and treatments under the Olay and SK-II brands. It also provides blades, razors, shave products, appliances, and other grooming products under the Braun, Gillette, and Venus brands. In addition, the company offers toothbrushes, toothpastes, and other oral care products under the Crest and Oral-B brands; and gastrointestinal, pain relief, rapid diagnostics, respiratory, vitamins/minerals/supplements, and other personal health care products under the Metamucil, Neurobion, Pepto-Bismol, and Vicks brands. Further, it provides fabric enhancers, and laundry additives and detergents under the Ariel, Downy, Gain, and Tide brands; and air and dish care, P&G professional, and surface care under the Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer brands. Additionally, the company offers baby wipes, and taped diapers and pants under the Luvs and Pampers brands; adult incontinence and menstrual care products under the Always, Always Discreet, and Tampax brands; and paper towels, tissues, and toilet papers under the Bounty, Charmin, and Puffs brands. It sells its products through mass merchandisers, social and e-commerce channels, grocery and specialty beauty stores, membership club stores, drug and department stores, distributors, wholesalers, airport duty-free and high-frequency stores, pharmacies, electronics stores, and professional channels, as well as directly to consumers. The Procter & Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio.

Sector
Consumer Defensive
Shares outstanding
2.34B

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$327.8B
P/E
20.9x
P/B
6.3x
EV / EBITDA
14.8x
EV / Sales
4.2x
P/S
3.9x
52-week high
$173.02
52-week low
$138.04

Profitability

Operating margin
24.3%
Net margin
18.6%
EBITDA margin
28.4%
ROE
30.2%
ROCE
24.6%
ROA
12.5%
Asset turnover
0.67

Growth

Revenue
$84.3B
Revenue growth, 1Y
0.3%
Revenue CAGR, 3Y
1.7%
Net profit growth, 1Y
7.4%
Free cash flow
$14.0B

Solvency

Current ratio
0.70
Debt / Equity
0.68
Debt / Assets
0.28
CFO / Net profit
1.14
Cash / Market cap
2.9%

Where the revenue went

Of every $100 of FY2025 revenue, $19 was left as net income.

The Procter & Gamble Company income statement flow, FY2025
The Procter & Gamble Company income statement flow, FY2025: flows
FromToAmount
RevenueCost of revenue$41.2B
RevenueGross profit$43.1B
Gross profitSelling, general and administrative$22.7B
Gross profitOperating income$20.5B
Operating incomePretax income$20.2B
Operating incomeInterest and other expense$284.0M
Pretax incomeTax and other$4.2B
Pretax incomeNet income$16.0B

Revenue and net profit

Revenue grew 0.3% in FY2025; net profit is the dashed line.

The Procter & Gamble Company revenue and net profit by fiscal year
The Procter & Gamble Company revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$80.2B$14.7B
FY2023$82.0B$14.7B
FY2024$84.0B$14.9B
FY2025$84.3B$16.0B

Cash flows

FY2025: $17.8B from operations, $14.0B free after investment (dashed).

The Procter & Gamble Company operating and free cash flow by fiscal year
The Procter & Gamble Company operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022$16.7B$13.6B
FY2023$16.8B$13.8B
FY2024$19.8B$16.5B
FY2025$17.8B$14.0B

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$84.3B+0.3%1Y
EBITDA
$23.9B+5.9%1Y
Net profit
$16.0B+7.4%1Y
Cash from operations
$17.8B-10.2%1Y
Free cash flow
$14.0B-15.0%1Y
Revenue CAGR, 3Y
1.7%
Net profit CAGR, 3Y
2.7%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$84.3B$23.9B$16.0B$14.0B31.2%+0.3%+7.4%

Monthly returns

Month-by-month returns of PG across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$125.2B
Liabilities$72.9B
Equity$52.3B
Paid-in capital$68.8B
Retained earnings$130.0B
Treasury stock$138.7B
Minority interest$272.0M

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Consumer Defensive companies placed by value, growth and quality; PG highlighted.

P/E against peers

PG trades at 20.9x earnings against a peer median of 28.6x (a 27% discount).

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
The Procter & Gamble CompanyPGthis companyP/E ↓ discount$327.8B20.9x6.3x30.2%14.8x
Costco Wholesale CorporationCOST$431.2B53.2x14.8x27.8%31.7x
The Coca-Cola CompanyKO$330.5B25.2x10.3x40.7%19.6x
Philip Morris International Inc.PM$272.7B24.0x-27.3x-113.5%18.1x
PepsiCo, Inc.PEP$194.3B23.6x9.5x40.4%15.1x
Altria Group, Inc.MO$117.9B17.0x-33.7x-198.4%12.8x
Monster Beverage CorporationMNST$86.6B45.4x10.5x23.1%33.2x
Mondelez International, Inc.MDLZ$78.3B31.9x3.0x9.5%19.7x
Colgate-Palmolive CompanyCL$68.1B31.9x1261.0x3948.1%19.1x
Peer median—28.6x9.9x25.4%19.3x

Year-to-date ROI

PG since 1 January, against earlier years.

Historical volatility

PG's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

The Procter & Gamble Company operating margin by fiscal year
The Procter & Gamble Company operating margin by fiscal year
DateOperating margin
FY202222.2%
FY202322.1%
FY202423.7%
FY202524.3%
LineFY2025
Cost of revenueCost Of Revenue$41.2B
Gross profitGross Profit$43.1B
Operating expensesOperating Expense$22.7B
Selling, general and administrativeSelling General And Administration$22.7B
Total expensesTotal Expenses$63.8B
Pretax incomePretax Income$20.2B

Learn while you research

Academy chapters picked for The Procter & Gamble Company and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Cyclical vs Defensive StocksConsumer staples behave defensively across the business cycle.6 min read
  3. 03 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  4. 04 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →